Gasper J. LaRosa

Jones Day


Results 1 to 5 of 18
Most popular |Most recent

FDA Launches Review of Orange Book Patent Listing Practices

USA - June 6 2020 Citing its priority to facilitate the timely development and approval of generic drugs, the U.S. Food and Drug Administration ("FDA") solicits...

Cary Miller, Anthony M. Insogna, Colleen M. Heisey.

PTAB Bar Association - Thought Leader Summit Recap

USA - December 18 2019 In November, the PTAB Bar Association held its annual Thought Leader Summit. The Summit highlighted recent changes to PTAB practice, with a keynote...

Trial Court Denies Amendment of Contentions To Add Reexam Claims Following Successful IPR

USA - October 21 2019 What happens when patent claims are found unpatentable in inter partes review ("IPR") and new claims are subsequently added to that patent through ex...

Stephanie M. Brooker.

Lead Compound Analysis Not Applicable to Certain Method-of-Treatment Claims

USA - June 5 2019 The Situation: In a Hatch-Waxman litigation, a district court determined that the claims covering a method of using the drug everolimus to...

Jihong Lou Ph.D..

Precedential: PTAB Considers 314(a) Factors Even When Denying Under 325(d)

USA - May 13 2019 When exercising its broad discretion on whether to institute review, the PTAB is not limited to consideration of factors associated with the type of...